| 0 (0%) | 09-27 09:31 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.48 | 1-year : | 4.06 |
| Resists | First : | 2.98 | Second : | 3.48 |
| Pivot price | 2.85  |
|||
| Supports | First : | 2.74 |
Second : | 2.59 |
| MAs | MA(5) : | 2.86 |
MA(20) : | 2.84 |
| MA(100) : | 2.86 |
MA(250) : | 3.42 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 68.4 |
D(3) : | 65.6 |
| RSI | RSI(14): 52.9 |
|||
| 52-week | High : | 5.19 | Low : | 2.47 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ PXS ] has closed below upper band by 43.8%. Bollinger Bands are 50.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.95 - 2.97 | 2.97 - 2.99 |
| Low: | 2.79 - 2.81 | 2.81 - 2.83 |
| Close: | 2.84 - 2.87 | 2.87 - 2.89 |
Fri, 26 Sep 2025
(PXS) Strategic Equity Report (PXS:CA) - news.stocktradersdaily.com
Fri, 12 Sep 2025
Phase I trial finds topical PXS-6302 generally well tolerated in established skin scars - Medical Xpress
Mon, 11 Aug 2025
Syntara’s stock plunges 52% following FDA request for added trial - BioWorld MedTech
Wed, 06 Aug 2025
Pyxis Tankers Inc. to Release Second Quarter 2025 Financial Results on August 8, 2025 - Quiver Quantitative
Wed, 06 Aug 2025
Pyxis Tankers to Reveal Q2 2025 Earnings: Petroleum Shipping Giant Reports Pre-Market August 8 - Stock Titan
Wed, 04 Jun 2025
So, What Happens Now With Illinois Sports Betting? - Sports Betting Dime
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 10 (M) |
| Shares Float | 4 (M) |
| Held by Insiders | 58.3 (%) |
| Held by Institutions | 1.8 (%) |
| Shares Short | 22 (K) |
| Shares Short P.Month | 25 (K) |
| EPS | -0.02 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.77 |
| Profit Margin | 6.2 % |
| Operating Margin | -9.5 % |
| Return on Assets (ttm) | 2.1 % |
| Return on Equity (ttm) | 2.1 % |
| Qtrly Rev. Growth | -34.3 % |
| Gross Profit (p.s.) | 2.1 |
| Sales Per Share | 4.24 |
| EBITDA (p.s.) | 1.36 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 16 (M) |
| Levered Free Cash Flow | 15 (M) |
| PE Ratio | -143.25 |
| PEG Ratio | 0 |
| Price to Book value | 0.32 |
| Price to Sales | 0.67 |
| Price to Cash Flow | 1.91 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|